Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trial.

Andrew Song,Keyue Ding,Normand Laperriere,James R. Perry,Warren P. Mason,Chad Winch,Christopher J. OCallaghan,Johan Menten,Alba A. Brandes,Claire Phillips,Michael Fay,Ryo Nishikawa,David Osoba,Gregory Cairncross,Wilson Roa,Wolfgang Wick,Wenyin Shi

Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trial.

2020

Andrew Song
Keyue Ding
Normand Laperriere
James R. Perry
Warren P. Mason
Chad Winch
Christopher J. OCallaghan
Johan Menten
Alba A. Brandes
Claire Phillips
Michael Fay
Ryo Nishikawa
David Osoba
Gregory Cairncross
Wilson Roa
Wolfgang Wick
Wenyin Shi

2547Background: Lymphopenia (LMP) may lead to worse outcomes for patients with glioblastoma (GBM). This study is a secondary analysis of the CCTG CE.6 trial evaluating the impact of chemotherapy an...

Keywords:

Physical therapy
Internal medicine
secondary analysis
Oncology
Glioblastoma
Randomized controlled trial
Medicine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations